Income tax expense · 2011–2025
Regeneron Pharmaceuticals income tax expense
$726M+97.6% · FY2025
Regeneron Pharmaceuticals (REGN) reported $726M in income tax expense for fiscal 2025, +97.6% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $726M | +97.6% | Open → |
| FY20242024-12-31 | $367M | +49.5% | Open → |
| FY20232023-12-31 | $246M | −52.8% | Open → |
| FY20222022-12-31 | $520M | −58.4% | Open → |
| FY20212021-12-31 | $1.3B | +320.8% | Open → |
| FY20202020-12-31 | $297M | −5.1% | Open → |
| FY20192019-12-31 | $313M | +187.2% | Open → |
| FY20182018-12-31 | $109M | −87.6% | Open → |
| FY20172017-12-31 | $880M | +102.6% | Open → |
| FY20162016-12-31 | $434M | −26.3% | Open → |
| FY20152015-12-31 | $589M | +39.2% | Open → |
| FY20142014-12-31 | $423M | +49.7% | Open → |
| FY20132013-12-31 | $283M | +$618M | Open → |
| FY20122012-12-31 | −$336M | −$335M | Open → |
| FY20112011-12-31 | −$1.1M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regeneron Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/regeneron-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regeneron Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/regeneron-pharmaceuticals/income-tax-expenseBibTeX
@misc{companiesranked-en-company-regeneron-pharmaceuticals-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Regeneron Pharmaceuticals income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regeneron-pharmaceuticals/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000872589-26-000008 · February 4, 2026
{{cite web |title=Regeneron Pharmaceuticals income tax expense — 10-K (0000872589-26-000008) |url=https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.